|
|||||
|
|
Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial |
|
| Authors: | Firsching Raimund,Piek Jürgen,Skalej Martin,Rohde Veit,Schmidt Uwe,Striggow Frank KN- Study Group |
| Affiliation: | Klinik für Neurochirurgie, Universit?tsklinikum, Otto-von-Guericke-Universit?t Magdeburg, Magdeburg, Germany. raimund.firsching@med.ovgu.de |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |